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The effect of naringenin, a flavonoid found in grapefruit, orange, and tomato, on lipid peroxidation and histopathological 
changes in the liver and kidneys of alloxan-induced diabetic mice were investigated. Two days after alloxan injection 
(75 mg kg-1, i.v.), naringenin ethanolic solution (0.5 % v/v) was given to mice intraperitoneally (50 mg kg-1 per day) for 
seven days. Naringenin’s impact on lipid peroxidation was measured by the 2-thiobarbituric acid test and histopathological 
changes were examined under a light microscope. Naringenin administration resulted in a significant decrease of lipid 
peroxidation level in liver and kidney tissue, as well as in a decreased number of vacuolated liver cells and degree of 
vacuolisation. Indications of tissue repair in kidney suggested that amelioration of diabetes-induced renal damage could 
be achieved over a longer period of time. Findings suggest that naringenin could be considered a dietary supplement in 
the prevention or treatment of diabetic complications and other diseases connected wih oxidative stress, and gives a hope 
that it could show similar effects in the treatment of diabetes in humans.
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Naringenin (2,3-dihydro-5,7-dihydroxy-2-(4-
hydroxyphenyl)-4H-1-benzopyran-4-one) is a flavonoid, a 
flavanone, mostly found in grapefruits, oranges and cooked 
tomato paste (1). It has been reported to show low toxicity 
and is therefore suitable as a dietary supplement (2). 
Naringenin has antioxidant, immunomodulatory, and anti-
inflammatory effect on the human body. It has been proven 
effective in the regulation of a variety of disorders related 
to diabetes and its complications (3, 4). Naringenin 
participates in the regulation of many metabolic and 
signaling pathways, like the regulation of liver apolipoprotein 
B, an indicator of atherosclerosis (3, 5, 6). Furthermore, 
Heo et al. (7) confirmed its neuroprotective effect by 
reducing the oxidative stress induced by amyloid beta-
protein-induced reactive oxygen species (ROS). Flavonoids 
may realise their protective role through several mechanisms 
like by activating and protecting intercellular antioxidant 
enzymes (8), or by directly or indirectly reacting with ROS 
through hydrogen atom transfer, single electron transfer or 
metal chelation (9). The antioxidant activity of flavonoids 
and their metabolites depends on their structural features, 
primarily the existence of functional hydroxyl groups in 
the B chain. An active 4’ hydroxyl group in the B ring of 
naringenin is found to be responsible for its antioxidant 
activity (2). Bioavailability of naringenin depends on its 
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source and form (1, 2, 10). It is possible to buy naringenin 
as a pure supplement but in natural products naringenin 
mainly occurs as naringenin-7-rhamnoglucoside or 
naringenin-7-glucoside. It has been reported that 
bioavailability of naringenin and naringenin-7-glucoside 
are similar, whereas naringenin-7-rhamnoglucoside exhibits 
slower absorption (2, 10).
Diabetes mellitus is a progressive and possibly the 
world’s fastest growing metabolic disorder which includes 
hyperglycaemia and oxidative stress as both a cause and a 
consequence (8, 11). Hyperglycaemia generates ROS that 
cause oxidative damage to the whole body, particularly to 
the cardiovascular and immunological systems, nerves, 
liver, and kidneys (12). It also attenuates anti-oxidative 
mechanisms through nonenzymatic glycosylation of anti-
oxidant enzymes (8). The products of lipid peroxidation, 
lipid radicals and lipid peroxides, are associated with 
damage to the liver, kidneys, brain, blood vessels, and other 
organs and tissues (13).
In this study, we examined the effect of naringenin on 
lipid peroxidation and histopathological changes of the 
liver and kidneys caused by alloxan-induced diabetes in 
mice because the liver and kidneys are among the organs 
most sensitive to oxidative stress in diabetes. The goal of 
our research was to find out more about the action of 
naringenin on the body affected by diabetes so it could be 
better evaluated as a potential therapeutic agent.
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Swiss albino inbred mice, male and female, 60 to 70 
days old, weighing 20 to 25 g, were obtained from the 
Department of Animal Physiology, Faculty of Science, 
University of Zagreb. They were fed a standard laboratory 
diet (4 RF 21, Mucedola, Settimo Milanese, Italy), tap water 
was given ad libitum and they were kept in individual cages 
at 12 h light: 12 h dark cycle. The animals were treated in 
compliance with the guidelines in force in the Republic of 
Croatia (Law on the Welfare of Animals, N.N. #19, 1999) 
and with the Guide for the Care and Use of Laboratory 
Animals, DHHS Publ. # (NIH) 86-123. The Ethical 
Committee of the Faculty of Science, University of Zagreb, 
Croatia, approved the study.
Chemicals and apparatus
Naringenin and Tween-40 (polyoxyethylene sorbitan 
monopalmitate) were purchased from Sigma-Aldrich 
Chemical Co. (USA). Prior to use, naringenin was dissolved 
in saline solution with 0.5 % v/v ethanol. Perkin Elmer 
Lambda 25 spectrophotometer (Perkin Elmer, USA) was 
used for absorbance measurements. Photomicrographs were 
taken by a digital camera (Nikon DMX1200) and Imaging 
Software Lucia G 4.80 (Laboratory Imaging Ltd., Prague, 
Czech Republic).
Experimental design 
Thirty-nine mice were randomly divided into three 
groups, as follows:
Group (i): nondiabetic animals who received 0.5 mL of 
saline solution with 0.5 % v/v ethanol per day by 
intraperitoneal (i.p.) injection for seven days;
Group (ii): diabetic animals who were administered 
alloxan intravenously (i.v.) in a single dose of 75 mg kg-1 
body weight; these served as the untreated diabetic group. 
They received 0.5 mL of saline solution with 0.5 % v/v 
ethanol per day by i.p. injection for seven days;
Group (iii): naringenin group; diabetic animals (alloxan-
induced) who received a naringenin solution i.p. in a daily 
dose of 50 mg kg-1 for seven days, beginning two days after 
the alloxan injection; these served as the naringenin-treated 
diabetic group. 
Five mice from each group were used for the 
experiments.
Induction of experimental diabetes and determination of 
serum glucose levels
The induction of diabetes by a single intravenous 
injection of freshly prepared saline solution of alloxan 
monohydrate (75 mg kg-1, i.v.) and the selection of animals 
for the study were carried out as described in our previous 
research (14).
Tissue harvesting
Five mice from each group were sacrificed by cervical 
dislocation on the ninth day after the alloxan injection. 
Subsequently the whole liver and kidneys were harvested 
for the determination of lipid peroxidation and 
histopathological analysis.
Determination of lipid peroxidation 
Samples of liver and kidney tissue were prepared as 
described in our previous research (9). Lipid peroxidation 
was determined as described by Nabavi et al. (15). For the 
construction of calibration curve, tetramethoxypropane was 
used. The levels of lipid peroxides were expressed as nmoles 
of malondialdehyde (MDA) formed per mg-1 protein. 
Protein concentration was determined as described by 
Navarro et al. (16). Crystalline bovine serum albumin was 
used for calibration curve.
Histopathological analysis
Histopathological analysis was conducted as described 
in our previous research (14). Liver tissue sections were 
examined for lymphocyte infiltrations and vacuolisation. 
Kidney sections were examined for lymphocyte infiltrations, 
changes in renal corpuscles, and renal tubules.
Statistical analyses
The results are representative of three independent 
experiments and were expressed as mean ± SD. Statistical 
comparisons were made using Student’s t-test. For statistical 
analyses we used GraphPad Prism version 5.01 for 
Windows, GraphPad Software, San Diego California USA, 
www.graphpad.com. The level of statistical significance 
was set at p<0.05.
RESULTS AND DISCUSSION
Naringenin, a naturally occurring flavonoid found in 
citrus fruits, is known to have anticarcinogenic, antidiabetic, 
antiosteoporetic, and anti-atherosclerotic properties (2, 17, 
18). Many studies have shown positive effects of plant 
extracts (18), but it is also necessary to know what effects 
a particular component of the extract has. Furthermore, we 
must consider possible toxic effects from plant extracts 
(19). We therefore decided to use pure naringenin. Different 
studies use different doses and different ways of drug 
application, like peroral and intraperitoneal. We decided to 
administer naringenin to mice intraperitoneally (50 mg kg-1 
per day) because this type of application and this dose are 
frequently used and they have proven to be non-toxic. 
Furthermore, some studies show that naringenin taken 
perorarly and intraperitoneally shows similar activity (20) 
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and a dose of 50 mg kg-1 for a mouse corresponds to a dose 
of 4 mg for a human. For an average person that would be 
about 250 mg of naringenin, which can be found in about 
half a liter of grapefruit juice (20-22). Our previous results 
(4) demonstrated that diabetic mice treated with naringenin 
survived a period of 50 days and after a critical period of 
three to seven days their appearance and behaviour did not 
differ from those of the healthy mice; suggesting a 
protective effect of naringenin on the organism. Furthermore, 
comet assay showed that naringenin reduced the level of 
DNA damage in lymphocytes but did not affect the level 
of DNA damage in the liver and kidneys. Since oxidative 
stress plays a pivotal role in the development of complications 
in diabetes, and positive effects of naringenin in the control 
of diabetes and other oxidative stress related diseases have 
been proven, we have explored the effect of naringenin on 
lipid peroxidation and histopathological changes of the liver 
and kidneys caused by alloxan-induced diabetes in mice. 
Lipid peroxidation in the liver and kidney tissue was 
significantly reduced in animals treated by naringenin 
compared to the untreated diabetic animals (Figure 1). 
Similarly, Cavia-Saiz et al. (23) showed than naringenin 
was able to inhibit lipid peroxidation in rat liver tissue 
induced by potent oxidants, hydroxyl radical and peroxyl 
radical. In carbon tetrachloride-induced nephrotoxicity, 
naringenin has also shown the ability for nephroprotection, 
as demonstrated by several assays, including the 
measurement of MDA in kidney tissue (24). The antioxidant 
activity of flavonoids and their metabolites depends on their 
structural features, like the arrangement of functional 
hydroxyl groups, O-methylation, differences in the main 
nuclear structure, such as the presence or absence of an 
unsaturated 2-3 bond and/or a 4-carbonyl group, degree of 
polymerisation and other (25). Naringenin’s antioxidant/
antiradical ability is based on its single 4’ hydroxyl group 
in the B ring of the molecule (2). However, structural 
features may not completely reflect the behaviour of 
naringenin in an organism. For example, it has been found 
that the antiradical activity of naringenin depends on the 
polarity of the solvent because hydrogen bonding 
interactions are a crucial factor which influences the 
reaction rate of this flavonoid and its antioxidant properties 
(26).
Furthermore, our results show that naringenin 
reduces histopathological changes in the liver and 
kidneys. Similarly to Khalil et al. (27), our histological 
analysis of liver tissue in the control mice with alloxan-
induced diabetes shows more or less vacuolated liver 
cells (Figure 2a,2b), a probable consequence of fat 
metabolism disorders. In half of the samples, the liver 
cells are more vacuolated around the central veins than 
around Kiernan’s spaces (Figure 2a). Besides vacuolated 
cells, lymphocyte infiltrations were also observed, 
suggesting inflammatory processes. In the second half 
of the samples, almost all cells were considerably 
vacuolated in the central and peripheral part of individual 
lobules (Figure 2b). In these samples, lymphocyte 
infiltrations were not found. In comparison with the 
untreated diabetic mice, the livers of the diabetic mice 
treated with naringenin showed a smaller amount of 
vacuolated cells with a lower degree of vacuolisation 
(Figure 2c, 2d), which confirms the beneficial effect of 
naringenin. A few small lymphocyte infiltrations were 
found in all the samples. Infiltrations were present in the 
parenchyma and next to the blood vessels in some 
Kiernan’s spaces (Figure 2d).
In the kidneys of the control diabetic mice, changes 
were found in the renal corpuscles and tubules. 
Bowman’s spaces of most renal corpuscles of the diabetic 
control mice were very narrow or completely reduced 
(Figure 3a, 3b, 3c), which was probably a consequence of 
the proliferation of mesangial and/or endothelial cells of 
the glomerulus. These results are in accordance with the 
results described by Prabhakar et al. (28) and Teoh et al. 
(29). In some corpuscles, the parietal layer of Bowman’s 
capsule, usually made of low squamous epithelium, was 
much thicker and composed of cubic cells (Figure 3b). 
Fioretto and Mauer (30) confirmed that mesangial 
expansion is the key structural transformation that leads to 
disturbances in the functioning of renal corpuscles in 
diabetes. However, Wolf et al. (31) showed that, besides 
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Figure 1 Levels of lipid peroxidation in a) liver and b) kidney of 
healthy (C), untreated diabetic mice (D) and diabetic mice treated 
with naringenin (N). Values are means ± SD (n = 4). (* statistical 
difference with untreated diabetic mice; ‡ statistical difference 
with healthy mice; Student’s t-test, p<0.05)
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mesangial expansion, the changes of the visceral layer of 
Bowman’s capsule can also affect the filtration barrier. Our 
analysis showed the thickening of the parietal layer of 
Bowman`s capsule (Figure 3b) and such changes may 
contribute to the reduction of Bowman’s space.
The tubule epithelium was damaged to varying 
degrees from one sample to the other. Tubules with 
cytoplasmic vacuolisation, intraluminal vacuoles, as well 
as with thinned epithelium with or without intraluminal 
eosinophilic mass were found (Figure 3a, 3c). The 
epithelium of some proximal tubules showed eosinophilic 
cytoplasm and reduced nucleus, i.e. the signs of necrosis 
(Figure 3a, 3b). Similar to our findings, Prabhakar et al. 
(28) described enlarged tubules and atrophy, and Teoh et 
al. (29) necrosis of proximal tubules. The vacuolated cells 
of proximal tubules and Henle’s loop were described in our 
previous study (14). A few small lymphocyte infiltrations 
were found in the interstitium in all of the samples. 
Tubular changes indicate disturbances in their function.
When we compared the kidney histology of the diabetic 
mice treated with naringenin to the untreated diabetic mice, 
no significant structural changes were observed, although 
in some mice more or less basophilic tubules indicated 
attempts to regenerate damaged epithelium (Figure 3d). 
Differences in the impact of naringenin on the liver and 
kidney tissue could be due to the effect of the first pass 
through the liver, where some ingredients with antioxidant 
properties undergo biotransformation. This may prevent or 
prolong the possible beneficial effects in other tissues. 
Furthermore, the liver is rich in antioxidant enzymes whose 
activities can be elevated by polyphenols (32) and can 
protect the liver and/or allow fast repair of damage. 
Although we did not find significant positive changes in the 
kidneys of the diabetic mice treated with naringenin for 
seven days, indications of tissue repair (Figure 3d) suggest 
that a better improvement of renal damage could be 
achieved over a longer period of time. This suggestion is 
supported by the study conducted by Renugadevi and 
Milton Prabu (33), which showed that the co-administration 
of naringenin and Cd for 28 days markedly reduced lipid 
peroxidation and preserved the normal histology of the renal 
tissue of diabetic rats. In addition, this suggestion is 
supported by the results of our previous study (34) where 
in a short period of time propolis failed to significantly 
affect the pathological changes in the kidneys, as well as 
the results of a study conducted by El Agawany et al. (35) 
where longer propolis administration showed significantly 
better results.
Taking into account our results and reports from other 
researchers, the findings suggest that naringenin has a 
positive effect on the liver and kidneys, two organs most 
sensitive to oxidative stress and disorders of fat metabolism 
in diabetes. This study implies that naringenin and its natural 
sources, such as grapefruit juice, could be considered a 
dietary supplement in the prevention or treatment of diabetic 
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Figure 2 Liver tissue of diabetic mice stained with HE (200×)
(a-b) Control mice treated with ethanolic solution. (a) In part of 
the samples, the liver cells around the central veins (cv) are more 
vacuolated than the cells around Kiernan’s spaces (Ks). (b) The 
degree and distribution of vacuolated cells in the centre and 
periphery of lobules are equal in the second part of the samples. 
Most of the cells are considerably vacuolated. 
(c-d) Diabetic mice treated with ethanolic solution of naringenin 
have considerably less vacuolated cells compared to diabetic 
control. (c) In one part of the samples, there are fewer vacuolated 
cells in the area around the central vein (cv), and in the other part 
of the samples vacuolated cells are equally distributed throughout 
the lobules (d).
cv- central vein; Ks-Kiernan’s space; L-lymphocyte infiltration 
near vein in Kiernan’s space
Figure 3 Kidney tissue of diabetic mice stained with HE (200×, 
400×)
 (a-c) Control diabetic mice treated with ethanolic solution (a 
200×; b, c 400×). Intercapsular areas of most renal corpuscles 
(rc) are narrow (thin white arrows), and the outer layers of 
Bowman’s capsule thickened (thick white arrows). Renal tubules 
with vacuolated cytoplasm (thick black arrows), tubules with 
intraluminal vacuoles (t1), tubules with thinned epithelium (t2) 
with or without intraluminal smaller or larger eosinophilic masses, 
and eosinophilic tubules (t3) are signs of damage of the tubules 
epithelium.
(d) Diabetic mice treated with ethanolic solution of naringenin 
(200×). In the renal cortex, larger lymphocyte infiltrations (L) 
were found and slightly more tubules with thinned epithelium 
compared to diabetic control. Some basophilic tubules (bt) were 
also found
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complications and other diseases connected wih oxidative 
stress. However, further research is needed to address all 
the possible effects of naringenin in the regulation of 
metabolic and signaling pathways involved in oxidative 
stress in diabetes.
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Naringenin reducira histopatološke promjene u jetri i bubregu miševa s dijabetesom
Istražen je učinak naringenina, flavonoida dostupnoga iz grejpa, naranče i rajčice, na razinu lipidne peroksidacije te 
patohistološke promjene u jetri i bubregu miševa s dijabetesom prouzročenim aloksanom. Dva dana nakon injekcije 
aloksana (75 mg kg-1, iv) započeta je terapija etanolnom otopinom naringenina (0.5% v / v). Naringenin je injiciran 
miševima intraperitonealno u dozi od 50 mg kg-1 tijekom sedam dana. Učinak naringenina na razinu lipidne peroksidacije 
određen je metodom s tiobarbiturnom kiselinom, a histopatološke promjene jetre i bubrega utvrđene su svjetlosnim 
mikroskopom. Terapija naringeninom prouzročila je značajno smanjenje ne samo razine lipidne peroksidacije u tkivu 
jetre i bubrega nego i broja vakuoliziranih stanica jetre te stupnja njihove vakuolizacije. Naznake oporavka tkiva u bubregu 
navode na zaključak da bi dugotrajna terapija mogla smanjiti oštećenja bubrega prouzročena dijabetesom. Zaštitni učinak 
naringenina u razvoju dijabetičkih komplikacija u miševa daje nadu da je sličan, pozitivan učinak moguć i u ljudi.
KLJUČNE RIJEČI: dijabetes; dijabetička nefropatija; histopatologija; lipidna peroksidacija; naringenin; oštećenja jetre
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